NCT04820049View on ClinicalTrials.gov

F573 Ia Clinical Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

August 2, 2022

Study Completion Date

November 6, 2022

Conditions
TolerancePharmacokinetic
Interventions
DRUG

F573

F573 for injection

OTHER

Placebo

Water for injection

Trial Locations (1)

430022

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Beijing Continent Pharmaceutical Co, Ltd.

INDUSTRY

NCT04820049 - F573 Ia Clinical Trial | Biotech Hunter | Biotech Hunter